InVivoMAb anti-human CD4

Danzer H, Glaesner J, Baerenwaldt A, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. Elife. 2020,9. doi: 10.7554/eLife.55319

Homet Moreno B, Zaretsky JM, Garcia-Diaz A, et al. Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells. Cancer Immunol Res. 2016,4(10):845-857.

Klammt C, Novotná L, Li DT, et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol. 2015,16(9):961-9. doi: 10.1038/ni.3231

Billerbeck E, Horwitz JA, Labitt RN, et al. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol. 2013,191(4):1753-64. doi: 10.4049/jimmunol.1201518

Hepburn TW, Totoritis MC, Davis CB. Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis. Rheumatology (Oxford). 2003,42(1):54-61.